Role of anthropometric indices and long-term effect of vit-D supplementation on BioNTech, Pfizer vaccine side effect and immunoglobulin G response against SARS-CoV-2 in individuals with COVID-19; Randomized control trial
How to cite
Lateef, Hawal; Kamari, Negin; Rezayeian, Shahab. 2023. "Role of anthropometric indices and long-term effect of vit-D supplementation on BioNTech, Pfizer vaccine side effect and immunoglobulin G response against SARS-CoV-2 in individuals with COVID-19; Randomized control trial." AEA RCT Registry. AEARCTR-0011109. https://doi.org/10.1257/rct.11109-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
A 3-day food record questionnaire (one day off and two days non-off) was taken from 2 groups at the beginning of the study. On the day patients were diagnosed as infected, they were asked to start taking supplements for 4 weeks and come back 4 weeks later for the first dose of vaccine. Patients were again asked to continue taking the supplement. Six to eight weeks after the first dose of vaccination, patients returned for a second dose of vaccine and were again asked to continue taking the supplement. 4 weeks after the second dose of vaccination, participants were asked to return for blood collection. Thus, participants continued to take the supplement for 14-16 weeks.
Intervention
The present study will be a multi-center, one-to-one randomized clinical trial. Inclusion criteria for selection of subjects will be a positive test for covid-19. Exclusion criteria included: 1. who dose not receive a vaccine or who have received one dose of vaccine and dose not return for the second dose, 2. patients with receiving any supplements in the last 6 months,
A 3-day food record questionnaire (one day off and two days non-off) will be take from 2 groups at the beginning of the study. On the day patients will diagnosed as infected, they will be asked to start taking supplements for 4 weeks and come back 4 weeks later for the first dose of vaccine. Patients will again asked to continue taking the supplement. Six to eight weeks after the first dose of vaccination, patients will returned for a second dose of vaccine and again asked to continue taking the supplement. 4 weeks after the second dose of vaccination, participants will asked to return for blood collection. Thus, participants continued to take the supplement for 14-16 weeks.
Experimental design
The present study will be a multi-center, one-to-one randomized clinical trial. Inclusion criteria for selection of subjects will be a positive test for covid-19. Exclusion criteria included: 1. who dose not receive a vaccine or who have received one dose of vaccine and dose not return for the second dose, 2. patients with receiving any supplements in the last 6 months,
A 3-day food record questionnaire (one day off and two days non-off) will be take from 2 groups at the beginning of the study. On the day patients will diagnosed as infected, they will be asked to start taking supplements for 4 weeks and come back 4 weeks later for the first dose of vaccine. Patients will again asked to continue taking the supplement. Six to eight weeks after the first dose of vaccination, patients will returned for a second dose of vaccine and again asked to continue taking the supplement. 4 weeks after the second dose of vaccination, participants will asked to return for blood collection. Thus, participants continued to take the supplement for 14-16 weeks.
Design details
Cited by
No citation data available for this registration yet.